PT88670B - Processo de colagem e expressao do factor beta2 de crescimento de transformacao - Google Patents

Processo de colagem e expressao do factor beta2 de crescimento de transformacao Download PDF

Info

Publication number
PT88670B
PT88670B PT88670A PT8867088A PT88670B PT 88670 B PT88670 B PT 88670B PT 88670 A PT88670 A PT 88670A PT 8867088 A PT8867088 A PT 8867088A PT 88670 B PT88670 B PT 88670B
Authority
PT
Portugal
Prior art keywords
amino acid
tgf
quot
iacc
growth factor
Prior art date
Application number
PT88670A
Other languages
English (en)
Portuguese (pt)
Inventor
Anthony F Purchio
Linda Madisen
Nancy Webb
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of PT88670B publication Critical patent/PT88670B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT88670A 1987-10-06 1988-10-04 Processo de colagem e expressao do factor beta2 de crescimento de transformacao PT88670B (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10675287A 1987-10-06 1987-10-06
US14826788A 1988-01-25 1988-01-25
US23406588A 1988-08-18 1988-08-18

Publications (1)

Publication Number Publication Date
PT88670B true PT88670B (pt) 1992-12-31

Family

ID=27380183

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88670A PT88670B (pt) 1987-10-06 1988-10-04 Processo de colagem e expressao do factor beta2 de crescimento de transformacao

Country Status (22)

Country Link
JP (1) JPH02444A (da)
KR (1) KR970001236B1 (da)
CN (1) CN1035845A (da)
AT (1) AT398433B (da)
BE (1) BE1002693A5 (da)
CH (1) CH680002A5 (da)
DE (1) DE3833897C2 (da)
DK (1) DK556388A (da)
ES (1) ES2012556A6 (da)
FI (1) FI884546A (da)
FR (1) FR2621324B1 (da)
GB (1) GB2210620B8 (da)
GR (1) GR1000492B (da)
IE (1) IE60918B1 (da)
IL (1) IL87877A0 (da)
IT (1) IT1227957B (da)
MY (1) MY103779A (da)
NL (1) NL8802442A (da)
NO (1) NO884429L (da)
NZ (1) NZ226486A (da)
PT (1) PT88670B (da)
SE (1) SE8803528L (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
CN100389120C (zh) * 2005-04-12 2008-05-21 中国人民解放军第三军医大学野战外科研究所 封闭TGF-β1的反义寡核苷酸及其在制备治疗纤维化相关疾病药物中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169016B2 (en) * 1984-07-16 2004-04-28 Celtrix Pharmaceuticals, Inc. Polypeptide cartilage-inducing factors found in bone
IL78197A (en) * 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
WO1988003807A2 (en) * 1986-11-17 1988-06-02 Sandoz Ag Production and use of a novel t-cell suppressor factor
AU1340688A (en) * 1987-01-30 1988-08-24 Techne Corporation Transforming growth factor-beta
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity

Also Published As

Publication number Publication date
ATA245488A (de) 1994-04-15
SE8803528D0 (sv) 1988-10-05
SE8803528L (sv) 1989-04-07
JPH02444A (ja) 1990-01-05
KR890006814A (ko) 1989-06-16
IT8822213A0 (it) 1988-10-06
DE3833897A1 (de) 1989-05-03
DK556388D0 (da) 1988-10-05
FI884546A (fi) 1989-04-07
NO884429D0 (no) 1988-10-05
NL8802442A (nl) 1989-05-01
FR2621324B1 (fr) 1994-02-18
IE60918B1 (en) 1994-08-24
GB2210620A (en) 1989-06-14
IL87877A0 (en) 1989-03-31
CH680002A5 (da) 1992-05-29
IT1227957B (it) 1991-05-20
NO884429L (no) 1989-04-07
DE3833897C2 (de) 1997-03-20
FI884546A0 (fi) 1988-10-03
GB2210620B8 (en) 1995-07-17
GB2210620B (en) 1992-07-08
GR1000492B (el) 1992-07-30
CN1035845A (zh) 1989-09-27
MY103779A (en) 1993-09-30
IE883018L (en) 1989-04-06
BE1002693A5 (fr) 1991-05-07
ES2012556A6 (es) 1990-04-01
KR970001236B1 (ko) 1997-02-04
DK556388A (da) 1989-04-07
AT398433B (de) 1994-12-27
NZ226486A (en) 1991-08-27
FR2621324A1 (fr) 1989-04-07
GB8823448D0 (en) 1988-11-16

Similar Documents

Publication Publication Date Title
US5604293A (en) Recombinant human basic fibroblast growth factor
EP0593065B1 (en) Recombinant fibroblast growth factors
AU2021203492A1 (en) Nucleic acid vaccines
AU666142B2 (en) Viral recombinant vectors for expression in muscle cells
US5486599A (en) Construction and use of synthetic constructs encoding syndecan
ES2273434T3 (es) Obtencion de la eritropoyetina mediante activacion genica endogena.
US20030040042A1 (en) Recombinant fibroblast growth factors
JPH07184681A (ja) ヒトエリトロポエチン活性を有する糖タンパク質の生産方法
PT986644E (pt) Preparação de eritropoietina por activação genética endógena com promotores virais
WO1994001557A1 (en) Bone formation-inducing protein
EA005496B1 (ru) Растворимый гетеродимерный рецептор цитокина
PT86558B (pt) Processo para a preparacao de factores de desenvolvimento de fibroblastos basicos
JPH03224490A (ja) 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター
PT88670B (pt) Processo de colagem e expressao do factor beta2 de crescimento de transformacao
NZ507459A (en) Modifying the expression of the fsh beta gene by homologous recombination
AU630075B2 (en) Cloning and expression of transforming growth factor 2b
US6699968B1 (en) Construction and use of synthetic constructs encoding syndecan
WO2020005974A1 (en) Methods of treating clrn1-associated hearing loss and/or vision loss
US20240254197A1 (en) Engineered Human FVIII with Enhanced Secretion Ability and Clotting Activity
WO2023092864A1 (en) Engineered human fviii with enhanced secretion ability and clotting activity
US20210401910A1 (en) Expression vector, pharmaceutical composition and method for preparing the same
IL103749A (en) Method for production of transforming growth factor beta 2
US7247716B2 (en) Recombinant sequence, its preparation and use
JPH09295945A (ja) 成熟型骨誘導因子の製造方法
JPH0144317B2 (da)

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920604

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19981231